Latest News and Press Releases

Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants

Castellum Announces Pricing of $3.7 Million Public Offering of Common Stock

Castellum, Inc. (CTM) Announces Proposed Public Offering of Common Stock

Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering

ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...

HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will participate in a fireside chat at the...

Castellum, Inc. (the “Company”) (NYSE-American: CTM) closes on registered direct offering, consisting of the sale of 8,437,501 shares.

Castellum, Inc. (the “Company”) (NYSE-American: CTM) has entered into a securities purchase agreement with an institutional investor to purchase 8,437,501

SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant...